Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
January 3, 2025
Technology
-
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
January 3, 2025
-
BrainStorm Issues 2024 Letter to Shareholders
December 30, 2024
-
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
December 20, 2024
-
Scope Technologies Corp. Engages Percepture to Accelerate Growth of QSE Brand and Drive Client Acquisition in the Evolving Quantum Security Landscape
December 20, 2024
-
Banzai Signs Acquisition of Vidello, Growing TTM Revenue 59% to $17.3M and Adding $2.3M in EBITDA
December 20, 2024
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
December 20, 2024
-
Adcore Launches Proposaly.io in Closed Beta, Revolutionizing Sales Workflows for Businesses Worldwide
December 18, 2024
-
SEALSQ Partnering with Hedera in the Next Generation of Post-Quantum Semiconductors
December 17, 2024
-
Soluna and Gynger Partner to Make Sustainable AI Computing More Accessible with Flexible Financing
December 16, 2024
-
FOREWARN Partners with Bluegrass REALTORS®
December 13, 2024
-
Exodus Movement, Inc. Announces Uplist to NYSE American Exchange
December 13, 2024
-
INOVIO Announces Pricing of $30 Million Public Offering
December 13, 2024
-
Cemtrex’s Vicon Announces New Partnership with AI Chipmaker Hailo for its New Modular Camera System, NEXT(TM)
December 12, 2024
-
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma
December 12, 2024
-
New Asia Holdings Inc (NAHD) Announces Closing of Acquisition of Machfu Inc.
December 12, 2024